IRIS
GIANNANTONI, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.950
EU - Europa 19.760
AS - Asia 12.176
SA - Sud America 3.771
Continente sconosciuto - Info sul continente non disponibili 1.271
AF - Africa 635
OC - Oceania 71
Totale 71.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.528
SG - Singapore 4.398
CN - Cina 3.965
IT - Italia 3.807
GB - Regno Unito 3.278
BR - Brasile 3.159
IE - Irlanda 3.055
RU - Federazione Russa 2.779
FR - Francia 2.435
UA - Ucraina 2.271
HK - Hong Kong 1.275
VN - Vietnam 1.266
SE - Svezia 1.131
NG - Nigeria 355
FI - Finlandia 315
DE - Germania 288
AR - Argentina 215
CA - Canada 210
BD - Bangladesh 201
IN - India 192
NL - Olanda 134
TR - Turchia 126
ID - Indonesia 120
EC - Ecuador 119
IQ - Iraq 109
ZA - Sudafrica 105
MX - Messico 84
AU - Australia 66
CO - Colombia 65
PK - Pakistan 64
KR - Corea 61
VE - Venezuela 59
MY - Malesia 54
JP - Giappone 50
SA - Arabia Saudita 50
CL - Cile 47
MA - Marocco 47
EU - Europa 46
PY - Paraguay 42
AT - Austria 41
UZ - Uzbekistan 36
PE - Perù 28
PL - Polonia 28
RO - Romania 27
AE - Emirati Arabi Uniti 26
EG - Egitto 26
KE - Kenya 26
ES - Italia 25
UY - Uruguay 25
RS - Serbia 22
BE - Belgio 21
JO - Giordania 21
JM - Giamaica 19
KZ - Kazakistan 19
OM - Oman 18
CR - Costa Rica 17
NP - Nepal 17
TN - Tunisia 16
BG - Bulgaria 15
CH - Svizzera 15
DZ - Algeria 15
TT - Trinidad e Tobago 15
AZ - Azerbaigian 14
HN - Honduras 14
BZ - Belize 13
IL - Israele 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
CI - Costa d'Avorio 11
PH - Filippine 11
AL - Albania 10
AO - Angola 9
LB - Libano 9
SV - El Salvador 9
GR - Grecia 8
IR - Iran 8
BY - Bielorussia 7
IM - Isola di Man 7
AM - Armenia 6
GE - Georgia 6
NI - Nicaragua 6
SN - Senegal 6
TH - Thailandia 6
HR - Croazia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BH - Bahrain 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
PA - Panama 4
PR - Porto Rico 4
BS - Bahamas 3
GT - Guatemala 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
Totale 70.351
Salva come PNG Salva come JPEG
Città #
Dallas 10.136
Dublin 2.973
Southend 2.970
Jacksonville 2.530
Fairfield 2.289
Singapore 1.775
Ashburn 1.466
Milan 1.375
Hong Kong 1.259
Chandler 1.191
Princeton 1.019
Woodbridge 1.016
Wilmington 992
Seattle 853
Council Bluffs 823
Beijing 818
Houston 801
Cambridge 780
San Jose 748
The Dalles 691
Nanjing 683
Santa Clara 633
San Mateo 512
Rome 508
Moscow 485
Lauterbourg 449
Ho Chi Minh City 439
Abuja 353
Ann Arbor 308
Helsinki 294
Columbus 273
Hanoi 272
Los Angeles 251
New York 239
Boardman 235
Buffalo 235
Nanchang 225
Redondo Beach 223
São Paulo 223
San Diego 209
Figino 178
Siena 156
Dearborn 154
Shenyang 151
Changsha 136
Tianjin 133
Hebei 119
Turin 102
Hefei 98
San Francisco 95
Jiaxing 94
Toronto 90
Shanghai 87
Rio de Janeiro 84
Chicago 77
Norwalk 76
Kunming 72
Belo Horizonte 69
London 67
Naples 65
Da Nang 62
Bologna 60
Izmir 60
Seoul 59
Frankfurt am Main 58
Haiphong 56
Johannesburg 53
Curitiba 52
Guangzhou 51
Orem 51
Dhaka 49
Porto Alegre 49
Brasília 45
Palermo 45
Guarulhos 43
Tokyo 43
Atlanta 40
Brooklyn 40
Florence 40
Amsterdam 38
Phoenix 38
Sydney 38
Salvador 37
Zhengzhou 37
Quito 36
Munich 35
Baghdad 34
Kuala Lumpur 34
Vienna 33
Bari 32
Guayaquil 32
Jinan 32
Ribeirão Preto 31
Boston 30
Campinas 30
Santo André 30
Goiânia 29
Manchester 29
Genoa 28
Lanzhou 28
Totale 47.304
Salva come PNG Salva come JPEG
Nome #
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 7.641
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 490
Utilizzo degli Alfa-litici nelle donne con sintomi del basso tratto urinario 301
Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup 298
Urinary and bowel disfunction in autism spectrum disorder: a prospective, observational study 296
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 269
A Camey II Modified Neobladder: Long-Term Complications And Functional Results 245
Urodynamic findings and functional outcomes after laparoscopic sacrocolpopexy for symptomatic pelvic organ prolapse 244
A Camey II Modified Neobladder: Long-Term Complications And Functional Results 225
Pharmacologic goals in interstitial cystitis/bladder pain syndrome 209
Food-Specific IgG4 Antibody-Guided Exclusion Diet Improves Conditions of Patients with Chronic Pain 204
"Voiding dysfunction in post-comatose patients" 203
Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: A clinical algorithm from an Italian consensus statement 201
"Advanced analysis in the pressure flow-study: a comparison of methods". 196
Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial 193
"PSYCHOLOGICAL INVESTIGATION AND SEXUAL DYSFUNCTION IN SPINAL CORD INJURY WOMEN 192
"Psychological investigation and sexual dysfunction in spinal cord injury women". 192
"Valutazione neuro-urologica ed endoscopica ed attuali orientamenti terapeutici" 187
"Vesciche ileali di sostituzione: studio morfo-funzionale" 187
The impact of Mirabegron on sexual function in women with idiopathic overactive bladder 187
"Comparison of cystometric patterns in spinal cord injury and multiple sclerosis patients" 185
"Clean intermittent catheterization prevents upper urinary tract disease in long-term spinal cord injured (SCJ) patients" 185
"Continuous ambulatory urodynamic monitoring: its role in diagnosing female micturitional disorders" 184
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer 184
"In vitro study of passive vs electromotive mitomycin C diffusion in human bladder wall. Preliminary results". 183
"Anal sphincterometry: is it a good alternative to perineal floor EMG recordings?." 183
Usefulness of antibiotic prophylaxis in invasive urodynamics in fertile and in postmenopausal female subjects 183
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: a pilot study 183
"Neurological features and urological dysfunction in survivors from prolonged coma". 181
"Intravesical Capsaicin in the treatment of hyperactive bladder in Spinal Cord injury (SCI) patients". 180
Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence 179
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder 178
"In reply to Dr Silver" 177
Single-session supine bilateral percutaneous nephrolithotomy 177
An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders 176
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease 174
Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence 173
Endoscopic ballistic lithotripsy in the treatment of Bladder Calculi in patients with Neurogenic Voiding Dysfunction 172
Dyssynergia or asynergia? 171
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 170
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis 169
Assessment of botulinum A toxin high affinity SV2 receptors on normal human urothelial cells. 167
Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare System 167
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 166
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 166
Bladder and urethral sphincter function after radical retropubic prostatectomy: A prospective long-term study 165
Intravesical resiniferatoxin versus capsaicin in the treatment of detrusor hypereflexia in spinal cord injured patients 164
Resonance® metallic stent in patients with ureterocutaneostomies 163
"Management of functional voiding dysfunction in children by means of voiding biofeedback" 163
Two-year efficacy and safety of botulinum A toxin intravesical injections in patients affected by refractory painful bladder syndrome 162
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study) 162
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder 161
"The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis" 160
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study 160
Urgency of micturition and detrusor contractility in men with prostatic obstruction and overactive bladders 160
Sequential intravesical bacillus Calmette-Guerin and electromotive mitomycin-C for high risk superficial bladder cancer: a prospective controlled study 160
Dermatomyositis Associated with Testicular Germ Cell Cancer 159
PUMA vs Romanzi in the detection of female bladder obstruction and detrusor contractility. 157
New frontiers in intravesical therapies and drug delivery 156
Thalidomide as therapy for the chronic pelvic pain syndrome (CPPS) 156
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up” 156
Botulinum A toxin intravesical injections improves sexual function in female patients affected by neurogenic detrusor overactivity 156
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis 155
Prostasomes and prostate cancer 155
Must colposuspension be associated with sacropexy to prevent postoperative urinary incontinence? 154
Stability of Resiniferatoxin stock solutions 153
Does the neobladder filling modulate soleus H reflex? 153
Clinical and neurophysiologic study of botulinum A toxin effect on neurogenic and idiopathic detrusor overactivity 153
Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial 153
Six-year follow-up of intradetrusorial injections of botulinum toxin type A in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results 152
Thalidomide as therapy for the chronic pelvic pain syndrome (CPPS) 152
Editorial comment on: Complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks 152
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study 151
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 151
Voiding dysfunction after radical retropubic prostatectomy: More than external urethral sphincter deficiency 150
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 150
Autonomic dysreflexia during urodynamics 150
Triage of functional, female and neuro-urology patients during and immediately after the COVID-19 outbreak 150
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group 149
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 149
Patient-reported outcomes in bladder pain syndrome: qui auget dolorem, auget et scientiam (as pain increases, so increases knowledge) 149
Tension-free vaginal tape (TVT) and trans-obturator suburethral tape (TOT) a prospective randomized trial 149
Preoperative MUCP and VLPP Did Not Predict Long-Term (4-Year) Outcome after Transobturator Mid-Urethral Sling 148
A prospective randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease 148
Intravesical administration of botulinum A toxin in spinal cord injured patients. Suburothelial versus intradetrusorial injections 148
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 148
Intravesical resiniferatoxin versus botulinum A toxin injections for the treatment of neurogenic detrusor overactivity 147
NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND DETRUSOR OVER ACTIVITY TREATED WITH TAMSULOSIN 147
Botulinum toxin a enters normal human urothelial cells and modulates the sensory activity of bladder urothelium 147
Comparative bladder wall tissue levels of resiniferatoxin 147
Is the one-hour pad-test useful in the assessment of urinary stress incontinence? 147
Treatment of neurogenic bladder in spinal cord injury (SCI) patients by means of clean intermittent catheterization (CIC): prevention of renal disease 147
Linking age, cystocele and abdominal straining 147
Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase 147
The Efficacy and Safety of Duloxetine in a Multidrug Regimen for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 147
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study 146
Hypospadias classification and repair: the riddle of the sphinx 146
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 146
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: a prospective randomized crossover study 146
Multicenter, randomized, phase III trial comparing radical retropubic prostatectomy with conventional external beam radiotherapy for localized prostate cancer: An interim report 146
Totale 24.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 225.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.465 0 0 0 377 31 133 66 254 187 591 342 1.484
2022/20236.043 542 162 961 1.178 549 1.433 60 360 532 67 115 84
2023/20243.317 152 87 273 92 83 990 1.130 56 20 87 54 293
2024/20257.999 202 708 284 565 527 189 78 349 901 640 1.292 2.264
2025/202627.316 1.257 4.721 7.603 2.729 2.638 800 2.189 781 788 909 440 2.461
2026/20274.139 1.260 877 1.999 3 0 0 0 0 0 0 0 0
Totale 71.634